NCT02554812 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID	NCT02554812
Title	A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Recruitment	Terminated
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Pfizer
Indications	urinary bladder cancer head and neck squamous cell carcinoma ovarian cancer Advanced Solid Tumor melanoma stomach cancer triple-receptor negative breast cancer lung non-small cell carcinoma
Therapies	Avelumab + PF-04518600 Avelumab + PD 0360324 Avelumab + Utomilumab Avelumab + PF-04518600 + Utomilumab
Age Groups:	senior \| adult
Covered Countries	USA \| POL \| GBR \| FRA \| CAN \| AUS

Additional content available in CKB BOOST